Volume 22, Issue 2 (6-2025)
J Res Dev Nurs Midw 2025, 22(2): 44-51 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Majdi F, Farshbaf-Khalili A, Mirzayi M, Hakimi P, Hajizadeh K, Shahnazi M. Comparing the effects of nettle extract with combined oral contraceptives on improving clinical and paraclinical symptoms of polycystic Ovary Syndrome: A triple-blind randomized controlled clinical trial. J Res Dev Nurs Midw 2025; 22 (2) :44-51
URL: http://nmj.goums.ac.ir/article-1-1981-en.html
URL: http://nmj.goums.ac.ir/article-1-1981-en.html
Faride Majdi1 
, Azizeh Farshbaf-Khalili2 , Mohammadreza Mirzayi3 , Parvin Hakimi4 , Khadije Hajizadeh5 , Mahnaz Shahnazi1
, Azizeh Farshbaf-Khalili2 , Mohammadreza Mirzayi3 , Parvin Hakimi4 , Khadije Hajizadeh5 , Mahnaz Shahnazi1
1- Department of Midwifery, Faculty of Nursing and Midwifery, Tabriz University of Medical sciences, Qazvin, Iran
2- Physical Medicine and Rehabilitation Research Centre, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran
3- Department of Traditional Medicine, School of Persian Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
4- Women’s Reproductive Health Research Center, Tabriz Universitu of Medical Sciences, Tabriz, Iran
5- Department of Midwifery, Faculty of Nursing and Midwifery, Tabriz University of Medical sciences, Qazvin, Iran ,hajizade_k@yahoo.com
2- Physical Medicine and Rehabilitation Research Centre, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran
3- Department of Traditional Medicine, School of Persian Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
4- Women’s Reproductive Health Research Center, Tabriz Universitu of Medical Sciences, Tabriz, Iran
5- Department of Midwifery, Faculty of Nursing and Midwifery, Tabriz University of Medical sciences, Qazvin, Iran ,
Abstract: (46 Views)
Background: Polycystic Ovary Syndrome (PCOS) is one of the most significant reproductive and endocrine disorders in women. This study aims to assess the impact of nettle extract on both clinical and paraclinical symptoms in women with PCOS.
Methods: This Triple-Blind Randomized Controlled Clinical Trial involved 60 women (n = 30 per group) aged 18 to 45, all diagnosed with PCOS based on definitive diagnostic criteria in Tabriz, Iran. Participants were randomly assigned in a 1:1 ratio using block sizes of 4 and 6 into two groups: an intervention group (receiving 500 mg of oral nettle extract containing flavonoids, tannins, and sterols daily for three months) and a control group (receiving combined oral contraceptives [COCs] for three months). Independent t-test and ANCOVA test were used in SPSS version 24 for data analysis. A p-value of <0.05 was considered statistically significant.
Results: The study showed that after the intervention, there were no statistically significant differences between the nettle extract group and the control group regarding mean levels of dehydroepiandrosterone sulfate (P=0.197), total testosterone (P=0.24), follicle-stimulating hormone (FSH) (P=0.549), luteinizing hormone (LH) (P=0.398), hirsutism score (P=0.149), or duration of menstrual bleeding (P=0.982), based on ANCOVA adjusted for baseline values, education level, and number of pregnancies. However, the two groups exhibited statistically significant differences in fasting blood glucose levels (P=0.020), intervals between menstrual bleeding (days) (P=0.031), and menstrual bleeding intensity (P = 0.008).
Conclusion: The findings indicate that nettle extract is as effective as low-dose oral contraceptive pills in reducing levels of dehydroepiandrosterone, total testosterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH), as well as in decreasing hirsutism scores and the duration of menstrual bleeding. Midwives can use nettle extract, which is a cheap, easy, and non-invasive method to improve PCO symptoms.
Methods: This Triple-Blind Randomized Controlled Clinical Trial involved 60 women (n = 30 per group) aged 18 to 45, all diagnosed with PCOS based on definitive diagnostic criteria in Tabriz, Iran. Participants were randomly assigned in a 1:1 ratio using block sizes of 4 and 6 into two groups: an intervention group (receiving 500 mg of oral nettle extract containing flavonoids, tannins, and sterols daily for three months) and a control group (receiving combined oral contraceptives [COCs] for three months). Independent t-test and ANCOVA test were used in SPSS version 24 for data analysis. A p-value of <0.05 was considered statistically significant.
Results: The study showed that after the intervention, there were no statistically significant differences between the nettle extract group and the control group regarding mean levels of dehydroepiandrosterone sulfate (P=0.197), total testosterone (P=0.24), follicle-stimulating hormone (FSH) (P=0.549), luteinizing hormone (LH) (P=0.398), hirsutism score (P=0.149), or duration of menstrual bleeding (P=0.982), based on ANCOVA adjusted for baseline values, education level, and number of pregnancies. However, the two groups exhibited statistically significant differences in fasting blood glucose levels (P=0.020), intervals between menstrual bleeding (days) (P=0.031), and menstrual bleeding intensity (P = 0.008).
Conclusion: The findings indicate that nettle extract is as effective as low-dose oral contraceptive pills in reducing levels of dehydroepiandrosterone, total testosterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH), as well as in decreasing hirsutism scores and the duration of menstrual bleeding. Midwives can use nettle extract, which is a cheap, easy, and non-invasive method to improve PCO symptoms.
Keywords: Nettle extract, Polycystic Ovary Syndrome, Contraceptives, Oral, Combined, Signs and Symptoms
Type of study: Original Article |
Subject:
Midwifery
References
1. Farhadi-Azar M, Behboudi-Gandevani S, Rahmati M, Mahboobifard F, Khalili Pouya E, Ramezani Tehrani F, et al. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study. Front Endocrinol (Lausanne). 2022;13:825528. [View at publisher] [DOI] [PMID] [Google Scholar]
2. Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev. 2016;37(5):467-520. [View at publisher] [DOI] [PMID] [Google Scholar]
3. Houston EJ, Templeman NM. Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS. J Endocrinol.
2025;265(2):e240269. [View at publisher] [DOI] [PMID] [Google Scholar]
4. Alam Z, Alseari S, Alameemi M, Alzaabi M, Alkhoori R, Östlundh L,et al. Prevalence of polycystic ovary syndrome among infertile women in the Gulf Cooperation Council (GCC) countries: A systematic review and meta-analysis. Heliyon. 2024;10(24):e40603. [View at publisher] [DOI] [PMID] [Google Scholar]
5. Bui LM, Aghajanova L, B. Lathi R, Sokalska A. Polycystic ovary syndrome and miscarriage: a narrative review. F&S Reviews. 2024.5(4): 100078. [View at Publisher] [DOI] [Google Scholar]
6. Vanky E, S. Løvvik T. Polycystic Ovary Syndrome and Pregnancy - From a Clinical Perspective. Curr Opin Endocr Metab Res. 2020;12:8-13. [View at publisher] [DOI] [Google Scholar]
7. Charalampakis V, Tahrani AA, Helmy A, Gupta JK, Singhal R. Polycystic ovary syndrome and endometrial hyperplasia: an overview of the role of bariatric surgery in female fertility. Eur J Obstet Gynecol Reprod Biol. 2016;207:220-6. [View at publisher] [DOI] [PMID] [Google Scholar]
8. Xue Z, Li J, Feng J, Han H, Zhao J, Zhang J, et al. Research Progress on the Mechanism Between Polycystic Ovary Syndrome and Abnormal Endometrium. Front Physiol. 2021;12:788772. [View at publisher] [DOI] [PMID] [Google Scholar]
9. Guan C, Zahid S, Minhas AS, Ouyang P, Vaught A, Baker VL,et al. Polycystic ovary syndrome: a "risk-enhancing " factor for cardiovascular disease. Fertil Steril. 2022;117(5):924-35. [View at publisher] [DOI] [PMID] [Google Scholar]
10. Sam S, Tasali E. Role of obstructive sleep apnea in metabolic risk in PCOS. Curr Opin Endocr Metab Res. 2021;17:46-51. [View at publisher] [DOI] [PMID] [Google Scholar]
11. Maliszewska B, Tokarzewska A, Łasica M, Małyszek M, Łaba L, Dziurda S, et al. Psychiatric disorders in women with polycystic ovary syndrome. J Pre Clin Clin Res. 2024;18(3):286-92. [View at publisher] [DOI] [Google Scholar]
12. Sukhapure M, Eggleston K, Fenton A, Frampton C, Porter RJ, Douglas KM. Changes in Mood, Anxiety, and Cognition with Polycystic Ovary Syndrome Treatment: A Longitudinal, Naturalistic Study. Neuropsychiatr Dis Treat. 2022;18:2703-12. [View at publisher] [DOI] [PMID] [Google Scholar]
13. ESHRE TR, Group A-SPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and sterility. 2004;81(1):19-25. [View at publisher] [DOI] [PMID] [Google Scholar]
14. Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):671-83. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Kim JJ. Obesity and Polycystic Ovary Syndrome. J Obes Metab Syndr 2024;33(4):289-301. [View at publisher] [DOI] [PMID] [Google Scholar]
16. Shele G, Genkil J, Speelman D. A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome. J Funct Morphol Kinesiol. 2020;5(2):35. [View at Publisher] [DOI] [PMID] [Google Scholar]
17. Yousuf SD, Ganie MA, Urwat U, Andrabi SM, Afzal Zargar M, Dar MA, et al. Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women. BMC Women's Health. 2023;23(1):68. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Escobar-Morreale HF, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P, et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2012;18(2):146-70. [View at Publisher] [DOI] [PMID] [Google Scholar]
19. Long T, Zhang Y, Zeng C, Zheng S, Zhou L, Liu H. Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study. Int J Endocrinol. 2022;2022:9927240. [View at Publisher] [DOI] [PMID] [Google Scholar]
20. Attia GM, Almouteri MM, Alnakhli FT. Role of Metformin in Polycystic Ovary Syndrome (PCOS)-Related Infertility. Cureus. 2023;15(8):e44493. [View at Publisher] [DOI] [PMID] [Google Scholar]
21. Shah D, Patil M. National PCOS Working Group. Consensus Statement on the Use of Oral Contraceptive Pills in Polycystic Ovarian Syndrome Women in India. J Hum Reprod Sci. 2018;11(2):96-118. [View at Publisher] [DOI] [PMID] [Google Scholar]
22. Messinis IE. Ovulation induction: a mini review. Hum Reprod. 2005;20(10):2688-97. [View at Publisher] [DOI] [PMID] [Google Scholar]
23. Takasaki A, Tamura I, Okada-Hayashi M, Orita T, Tanabe M, Maruyama S, et al. Usefulness of intermittent clomiphene citrate treatment for women with polycystic ovarian syndrome that is resistant to standard clomiphene citrate treatment. Reprod Med Biol. 2018;17(4):454-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
24. Kar S. Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: A prospective randomized trial. J Hum Reprod Sci. 2012;5(3):262-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
25. Sam S, Ehrmann DA. Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome. Diabetologia. 2017; 9(60):1656-61. [View at Publisher] [DOI] [PMID] [Google Scholar]
26. Nantia EA, Moundipa PF, Monsees TK, Carreau S. Medicinal plants as potential male anti-infertility agents: a review. Basic and Clinical Andrology. 2009;19(3):148-58. [View at Publisher] [DOI] [Google Scholar]
27. Khanage SG, Subhash TY, Bhaiyyasaheb IR. Herbal drugs for the treatment of Polycystic ovary syndrome (PCOS) and its complications. Pharmaceutical Research. 2019;2(1):5-13. [View at Publisher] [Google Scholar]
28. Asgarpanah J, Mohajerani R. Phytochemistry and pharmacologic properties of Urtica dioica L. Journal of medicinal plants research. 2012;6(46):5714-9. [View at Publisher] [DOI] [Google Scholar]
29. Mavi A, Terzi Z, Özgen U, Yildirim A, Coşkun M. Antioxidant properties of some medicinal plants: Prangos ferulacea (Apiaceae), Sedum sempervivoides (Crassulaceae), malva neglecta (malvaceae), Cruciata taurica (Rubiaceae), Rosa pimpinellifolia (Rosaceae), Galium verum subsp. verum (Rubiaceae), urtica dioica (urticaceae). Biol Pharm Bull. 2004;27(5):702-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
30. Gülçin I, Küfrevioǧlu Öİ, Oktay M, Büyükokuroǧlu ME. Antioxidant, antimicrobial, antiulcer and analgesic activities of nettle (Urtica dioica L.). J Ethnopharmacol. 2004;90(2-3):205-15. [View at Publisher] [DOI] [PMID] [Google Scholar]
31. Koch E. Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms. Planta med. 2001;67(06):489-500. [View at Publisher] [DOI] [PMID] [Google Scholar]
32. Hadizadeh I, Peivastegan B, Kolahi M. Antifungal activity of nettle (Urtica dioica L.), colocynth (Citrullus colocynthis L. Schrad), oleander (Nerium oleander L.) and konar (Ziziphus spina-christi L.) extracts on plants pathogenic fungi. Pak J Biol Sci. 2009;12(1):58-63. [View at publisher] [DOI] [PMID] [Google Scholar]
33. Zare S, Nabiuni M, Tayanloo A, Hoseini S, Karimzadeh-Bardei L. The effects of Urtica dioica extract on lipid profile, insulin resistance index and liver histology in polycystic ovary syndrome-induced Wistar rats. Am J Chin Med. 2015;1(2):23-33. [View at Publisher] [Google Scholar]
34. Shakibaei M, Allaway D, Nebrich S, Mobasheri A. Botanical extracts from rosehip (Rosa canina), willow bark (Salix alba), and nettle leaf (Urtica dioica) suppress IL-1-induced NF-κB activation in canine articular chondrocytes. Evid Based Complement Alternat Med. 2012;2012. [View at Publisher] [DOI] [PMID] [Google Scholar]
35. Zemmouri H, Sekiou O, Ammar S, El Feki A, Bouaziz M, Messarah M, et al. Urtica dioica attenuates ovalbumin-induced inflammation and lipid peroxidation of lung tissues in rat asthma model. Pharm Biol. 2017;55(1):1561-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
36. Azin F, Khazali H. Phytotherapy of polycystic ovary syndrome: A review. Int J Reprod Biomed. 2022;20(1):13-20. [View at Publisher] [DOI] [PMID] [Google Scholar]
37. Momeni H, Salehi A, Seraji A. study of Vitex Agnus Castus and Evening Primrose oil on Body Mass Index (BMI). CMJA. 2012;2(2):194-203 [View at Publisher] [Google Scholar]
38. Attarzadeh HR, Sardar M, Taghavi M, Ayaz KHF . The effects of an aerobic exercise program on LH, FSH, TST and DHEA levels in obese women with polycystic ovary syndrome. IJEM. 2012;14(1).39-46. [View at Publisher] [Google Scholar]
39. Higham JM, O'brien P, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990;97(8):734-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
40. Ramezani Tehrani F, Minooee S, Simbar M, Azizi F. A simpler diagnostic method to assess hirsutism in the Iranian population: Based on modified Ferriman-Gallwey scoring system (Tehran lipid and glucose study). Iranian Journal of Endocrinology and Metabolism. 2013;15(3):303-10. [View at Publisher] [Google Scholar]
41. Najafipour F, Rahimi AO, Mobaseri M, Agamohamadzadeh N, Nikoo A, Aliasgharzadeh A. Therapeutic effects of stinging nettle (Urtica dioica) in women with Hyperandrogenism. Int J Current Res Acad Rev. 2014;2(7):153-60 [View at Publisher] [Google Scholar]
42. Esfade H, Mirabolghasemi G, Azarnia M. The joint effect of hydro-alcoholic extract of nettle root and metformin on ovarian tissue of diabetic model of Wistar rat. Nova Biologica Reperta. 2019;6(2):131-9. [View at Publisher] [DOI] [Google Scholar]
43. Kianbakht S, Khalighi-Sigaroodi F, Dabaghian FH. Improved glycemic control in patients with advanced type 2 diabetes mellitus taking Urtica dioica leaf extract: a randomized double-blind placebo-controlled clinical trial. Clin Lab. 2013;59(9-10):1071-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
44. Fakhraee S, Jouyandeh Z, Mehri A, Larijani B, Hasaniranjbar S. Systematic review on the effectiveness and safety of nettle herb in treating diabetes. J Diabetes Metab Disord. 2012;12(6):507-23. [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
